Notificação de entrada na fase nacional - PCT
#1.3
11/29/2022
RPI 2708
Application data
Number
112022020881Type
Filing
Publication
PCT
SE2021050345 The application was filed at the INPI on 04/14/2021. It awaits formal examination and publication in the RPI gazette.
Latest action published by the INPI: 11/29/2022. We update with every new RPI gazette, published weekly.
Applicants
TX MEDIC AB
SE
Inventors
L. B. (pessoa física)
SE
IPC Classification
Priority claims
US
63/010,211 · 04/15/2020
Abstract
TRATAMENTO DA SEPSE E HIPERCITOCINEMIA. A invenção refere-se ao sulfato de dextrana, ou um salfarmaceuticamente aceitável do mesmo, no tratamento da sepse e hipercitocinemia.
Publications in the Brazilian Industrial Property Gazette (RPI).
#1.3
11/29/2022
RPI 2708
#1.1
10/25/2022
RPI 2703
From the same holder
Same category
Patent monitoring
Receive alerts on INPI events, decisions, and expiry dates for your portfolio.